These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 6339618

  • 1. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase.
    Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, Austen KF.
    J Immunol; 1983 Apr; 130(4):1891-5. PubMed ID: 6339618
    [Abstract] [Full Text] [Related]

  • 2. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
    Gervasoni JE, Conrad DH, Hugli TE, Schwartz LB, Ruddy S.
    J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of human high molecular weight kininogen by human mast cell tryptase.
    Maier M, Spragg J, Schwartz LB.
    J Immunol; 1983 May; 130(5):2352-6. PubMed ID: 6339626
    [Abstract] [Full Text] [Related]

  • 4. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB, Bradford TR, Littman BH, Wintroub BU.
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [Abstract] [Full Text] [Related]

  • 5. Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5.
    Fukuoka Y, Xia HZ, Sanchez-Muñoz LB, Dellinger AL, Escribano L, Schwartz LB.
    J Immunol; 2008 May 01; 180(9):6307-16. PubMed ID: 18424754
    [Abstract] [Full Text] [Related]

  • 6. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin.
    Minta JO, Man D, Movat HZ.
    J Immunol; 1977 Jun 01; 118(6):2192-8. PubMed ID: 864257
    [Abstract] [Full Text] [Related]

  • 7. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y, Hugli TE.
    J Immunol; 1988 May 15; 140(10):3496-501. PubMed ID: 3283237
    [Abstract] [Full Text] [Related]

  • 8. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
    Burger R, Zilow G, Bader A, Friedlein A, Naser W.
    J Immunol; 1988 Jul 15; 141(2):553-8. PubMed ID: 2454995
    [Abstract] [Full Text] [Related]

  • 9. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
    Burger R, Bader A, Kirschfink M, Rother U, Schrod L, Wörner I, Zilow G.
    Clin Exp Immunol; 1987 Jun 15; 68(3):703-11. PubMed ID: 3498585
    [Abstract] [Full Text] [Related]

  • 10. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
    del Balzo U, Polley MJ, Levi R.
    J Pharmacol Exp Ther; 1988 Sep 15; 246(3):911-6. PubMed ID: 2458450
    [Abstract] [Full Text] [Related]

  • 11. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ, Das C, Bennett D, Terman DS.
    J Immunol; 1984 Aug 15; 133(2):1057-63. PubMed ID: 6610702
    [Abstract] [Full Text] [Related]

  • 12. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
    Fukuoka Y, Hugli TE.
    J Immunol; 1990 Sep 15; 145(6):1851-8. PubMed ID: 1697312
    [Abstract] [Full Text] [Related]

  • 13. Generation, purification and functional characterization of three C3a anaphylatoxins in rainbow trout: role in leukocyte chemotaxis and respiratory burst.
    Rotllant J, Parra D, Peters R, Boshra H, Sunyer JO.
    Dev Comp Immunol; 2004 Jun 15; 28(7-8):815-28. PubMed ID: 15043949
    [Abstract] [Full Text] [Related]

  • 14. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.
    Maruo K, Akaike T, Ono T, Okamoto T, Maeda H.
    J Allergy Clin Immunol; 1997 Aug 15; 100(2):253-60. PubMed ID: 9275149
    [Abstract] [Full Text] [Related]

  • 15. Complement activation and generation of C3a anaphylatoxin by radiological contrast agents.
    Dawson P, Turner MW, Bradshaw A, Westaby S.
    Br J Radiol; 1983 Jul 15; 56(667):447-8. PubMed ID: 6602640
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug 15; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

  • 17. Generation of anaphylatoxin activity related to C3a, by treatment of human serum with the nitrogen nucleophile N2H4 or the chaotrope KSCN.
    von Zabern I, Damerau B, Nolte R, Grünefeld E, Vogt W.
    Scand J Immunol; 1985 Dec 15; 22(6):639-51. PubMed ID: 3937227
    [Abstract] [Full Text] [Related]

  • 18. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
    Meuer S, Becker S, Hadding U, Bitter-Suermann D.
    Z Immunitatsforsch Immunobiol; 1978 Mar 15; 154(2):135-46. PubMed ID: 77089
    [Abstract] [Full Text] [Related]

  • 19. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL, Ember JA, Herdman DS, DiScipio RG, Hugli TE, Gigli I.
    J Immunol; 1995 Jul 01; 155(1):266-74. PubMed ID: 7602103
    [Abstract] [Full Text] [Related]

  • 20. Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers.
    Addington AK, Johnson DA.
    Biochemistry; 1996 Oct 22; 35(42):13511-8. PubMed ID: 8885830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.